Lakiea Wright, MD: The Importance of Flu Vaccination

Video

An expert discusses the importance of getting vaccinated for the flu this year as well as strategies healthcare systems are taking to ensure easy access for patients.

The large overlap in symptoms between influenza (flu) and allergies means it can be difficult for healthcare providers to always make an accurate diagnosis. The start of autumn thus marks the onset of flu and fall allergy seasons, which may become all the more complicated during the ongoing coronavirus disease 2019 (COVID-19) pandemic.

In a recent interview with HCPLive®, Lakiea Wright, MD, allergy and immunity, Brigham and Women’s Hospital, stressed that during this pandemic it becomes all the more essential for healthcare providers and clinicians to encourage their patients to receive their flu vaccination.

Many providers and healthcare system have developed novel strategies to ensure that individuals have easy and safe access to the vaccination. For example, drive-through flu clinics have become a more prevalent means of administering the vaccine.

Previously, Wright explained that fever, sore throat, cough, and shortness of breath are typical overlapping symptoms between flu and allergies, as well as with COVID-19. Nonetheless, she emphasized the increasing necessity to utilize the healthcare resources that are currently available.

“Even though that the symptoms overlap, it’s really important to make sure that patients are vaccinated, which will be really important for this upcoming season.” she said.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.